Bulletin
Investor Alert

AbbVie Inc.

NYS: ABBV

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
AbbVie Inc.

After Hours

ABBV
/zigman2/quotes/202428675/composite

$

138.27

Change

+0.71 +0.52%

Volume

Volume 677,446

May 26, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202428675/composite

Previous close

$ 138.62

$ 137.56

Change

-1.06 -0.76%

Day low

Day high

$137.10

$139.85

Open
Open: 138.72

52 week low

52 week high

$134.09

$168.11

Open

Market cap

$242.70B

Average volume

5.71M

P/E ratio

32.39

Rev. per Employee

$1.13M

EPS

4.25

Dividend

1.48

Div yield

4.30%

Ex dividend date

4/13/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/abbv

MarketWatch News on ABBV

  2. Be Careful Buying Stocks Berkshire Purchases

    12:29 p.m. May 16, 2023

    - Andrew Bary

  3. Weight-Loss Drugs Will Be Blockbusters. Here’s the Stock to Buy.

    8:42 a.m. May 4, 2023

    - Josh Nathan-Kazis

  8. AbbVie Stock Falls as Humira Sales Drop

    11:20 a.m. April 27, 2023

    - Emily Dattilo

  11. AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations

    8:04 a.m. April 27, 2023

    - Tomi Kilgore

  12. Alphabet, Meta Platforms, Amazon.com and More

    10:19 p.m. April 23, 2023

    - Nicholas Jasinski

  14. These 6 Income Funds Use Options to Pump Up Their Yields

    3:30 a.m. April 21, 2023

    - Andrew Bary

  18. How the Top Women in Finance Are Shaping the Future

    6:47 p.m. March 18, 2023

    - Reshma Kapadia

  20. Biotech Has Fallen Hard. Now Could Be a Good Time to Buy.

    1:00 a.m. March 2, 2023

    - Lewis Braham

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/abbv

Other News on ABBV

  1. Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

    2:32 a.m. May 25, 2023

    - The Wall Street Journal Interactive Edition

  2. Drug Developer Acelyrin Raises $540 Million in IPO

    2:32 a.m. May 6, 2023

    - The Wall Street Journal Interactive Edition

  3. 10-Q: ABBVIE INC.

    1:00 p.m. May 5, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  4. Obesity Could Be Pharma’s Biggest Blockbuster Yet

    2:34 a.m. May 6, 2023

    - The Wall Street Journal Interactive Edition

  5. Merck to Buy Prometheus Biosciences

    8:02 a.m. April 17, 2023

    - The Wall Street Journal Interactive Edition

  6. UBS’s Sergio Ermotti Joins the Boomerang CEO Club

    5:36 p.m. March 29, 2023

    - The Wall Street Journal Interactive Edition

  7. First Drugs Facing Medicare Price Penalty Are Named

    3:57 a.m. March 16, 2023

    - The Wall Street Journal Interactive Edition

  8. New Drugs for Cancer, Rare Disease Can Cost Over $20,000 a Month

    3:35 a.m. March 10, 2023

    - The Wall Street Journal Interactive Edition

  9. Trust Investment Advisors Buys 2, Sells 3 in 4th Quarter

    1:00 p.m. Feb. 28, 2023

    - GuruFocus.com

  10. Top 5 4th Quarter Trades of OLD REPUBLIC INTERNATIONAL CORP

    9:00 p.m. Feb. 21, 2023

    - GuruFocus.com

  11. Top 5 4th Quarter Trades of Personal Capital Advisors Corp

    5:00 p.m. Feb. 20, 2023

    - GuruFocus.com

  12. HealthCor Management, L.P. Buys 2, Sells 3 in 4th Quarter

    5:00 p.m. Feb. 20, 2023

    - GuruFocus.com

  14. Top 5 4th Quarter Trades of ORBIMED ADVISORS LLC

    1:00 a.m. Feb. 18, 2023

    - GuruFocus.com

  15. 10-K: ABBVIE INC.

    1:59 p.m. Feb. 17, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  16. Robert Bruce Buys 1, Sells 4 in 4th Quarter

    1:00 p.m. Feb. 15, 2023

    - GuruFocus.com

  17. Eye-Care Company Bausch + Lomb Names Brent Saunders CEO

    3:33 a.m. Feb. 16, 2023

    - The Wall Street Journal Interactive Edition

  18. The End of Abbvie’s $200 Billion Monopoly Won’t Sink the Stock

    3:34 a.m. Feb. 10, 2023

    - The Wall Street Journal Interactive Edition

  19. Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again

    3:35 a.m. Feb. 10, 2023

    - The Wall Street Journal Interactive Edition

  20. AF Advisors, Inc.'s Top 5 Sells of the 4th Quarter

    11:00 a.m. Feb. 8, 2023

    - GuruFocus.com

  21. Loading more headlines...
/news/pressrelease/company/us/abbv

Press Releases on ABBV

  2. SKINVIVE™ by JUVÉDERM® Receives U.S. FDA Approval

    8:45 a.m. May 15, 2023

    - PR Newswire - PRF

  5. AbbVie Reports First-Quarter 2023 Financial Results

    7:32 a.m. April 27, 2023

    - PR Newswire - PRF

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.